FDAFDA · Food and drugs·Recall number D-1388-2012
Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05
Published June 27, 2012 · Recall initiated: May 14, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ZEMPLAR
- Manufacturer
- Abbott Laboratories
- Distributor
- Nationwide
- Lot
- Lot #: 11-122-DK, Exp 10/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.